It was a harsh winter morning in October 2019 in a Jammu village, when Makhno Devi took her 11-year-old son, Rutav, to the nearest sub-district hospital.
For three days, Rutav had stopped urinating, his body temperature had risen and he was refusing to eat.
But doctors at the hospital in Ramnagar town struggled to treat the boy. By evening, they referred him to the district hospital in Udhampur and gave Makhno an ambulance.
Udhampur was 36 km away, a ride over hilly terrain. Rutav died on the way.
Thirty-eight-year-old Makhno, who grows maize on a small farmland in Kirmoo village, said that the ambulance driver left the family on the road with the body. For the next three months, no health team visited her to ask about Rutav’s death.
Then in February 2020, she was told that her son’s death had been caused by a contaminated cough syrup she had forced him to gulp down for three days, a syrup she had bought off the counter from a chemist in Ramnagar.
Thirteen more children died in Jammu’s Ramnagar district after Rutav – all of them had consumed Coldbest-PC cough syrup. Six who survived were left with permanent disabilities.
The syrup had been manufactured 500 km away in Himachal Pradesh’s Sirmaur district by pharmaceutical company...
Read more
You may also like
Travel Tips: Love to travel but get an upset stomach? Try these effective tips..
Ryanair's major ticket change - 3 key questions answered about November 2025 plan
No one from Bengal administration reached out to us, says father of Durgapur gang-rape victim
ISSF World C'ship Shotgun: Focus shifts to trap events as India look to renew medal hunt
Bihar polls: BJP's candidate list reflects caste and gender balance